FR2568142A1 - - Google Patents
Download PDFInfo
- Publication number
- FR2568142A1 FR2568142A1 FR8411862A FR8411862A FR2568142A1 FR 2568142 A1 FR2568142 A1 FR 2568142A1 FR 8411862 A FR8411862 A FR 8411862A FR 8411862 A FR8411862 A FR 8411862A FR 2568142 A1 FR2568142 A1 FR 2568142A1
- Authority
- FR
- France
- Prior art keywords
- lanolate
- oil
- emulsion
- water
- emulsions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000839 emulsion Substances 0.000 claims abstract description 44
- 239000002253 acid Substances 0.000 claims abstract description 19
- 229930182558 Sterol Natural products 0.000 claims abstract description 15
- 150000003432 sterols Chemical class 0.000 claims abstract description 15
- 235000003702 sterols Nutrition 0.000 claims abstract description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 229910052751 metal Inorganic materials 0.000 claims description 15
- 239000002184 metal Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 13
- 235000012000 cholesterol Nutrition 0.000 claims description 13
- 229910052749 magnesium Inorganic materials 0.000 claims description 13
- 239000011777 magnesium Substances 0.000 claims description 13
- 230000001804 emulsifying effect Effects 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 7
- 229910052802 copper Inorganic materials 0.000 claims description 7
- 239000010949 copper Substances 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 229950005143 sitosterol Drugs 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 7
- 239000008271 cosmetic emulsion Substances 0.000 abstract 1
- 239000008251 pharmaceutical emulsion Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 43
- 235000019198 oils Nutrition 0.000 description 37
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 36
- 238000000034 method Methods 0.000 description 14
- 229940099259 vaseline Drugs 0.000 description 14
- 230000003020 moisturizing effect Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 11
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 11
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 11
- 229960002216 methylparaben Drugs 0.000 description 11
- 239000004166 Lanolin Substances 0.000 description 8
- -1 cholesterol Chemical class 0.000 description 8
- 235000019388 lanolin Nutrition 0.000 description 8
- 229940039717 lanolin Drugs 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000004264 Petrolatum Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940066842 petrolatum Drugs 0.000 description 5
- 235000019271 petrolatum Nutrition 0.000 description 5
- 239000007957 coemulsifier Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 3
- 239000005662 Paraffin oil Substances 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 229960002537 betamethasone Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical class CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 2
- 239000011654 magnesium acetate Substances 0.000 description 2
- 229940069446 magnesium acetate Drugs 0.000 description 2
- 235000011285 magnesium acetate Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- WYQPLTPSGFELIB-JTQPXKBDSA-N Difluprednate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2CC[C@@](C(=O)COC(C)=O)(OC(=O)CCC)[C@@]2(C)C[C@@H]1O WYQPLTPSGFELIB-JTQPXKBDSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000384507 Hoplostethus Species 0.000 description 1
- 241000243251 Hydra Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- YJVBLROMQZEFPA-UHFFFAOYSA-L acid red 26 Chemical compound [Na+].[Na+].CC1=CC(C)=CC=C1N=NC1=C(O)C(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=CC=C12 YJVBLROMQZEFPA-UHFFFAOYSA-L 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960004875 difluprednate Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960002311 dithranol Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HQMNCQVAMBCHCO-DJRRULDNSA-N etretinate Chemical compound CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C HQMNCQVAMBCHCO-DJRRULDNSA-N 0.000 description 1
- 229960002199 etretinate Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/34—Higher-molecular-weight carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/38—Alcohols, e.g. oxidation products of paraffins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
Abstract
L'INVENTION EST RELATIVE A UN SYSTEME EMULSIONNANT POUR EMULSIONS DU TYPE EAU-DANS-L'HUILE. CE SYSTEME EMULSIONNANT EST CONSTITUE D'UN LANOLATE DE METAL ALCALINO-TERREUX OU METALLIQUE ET D'UN STEROL, LEDIT LANOLATE ETANT OBTENU PAR ACTION DIRECTE DE L'ACIDE LANOLIQUE ET D'UN ACETATE ALCALINO-TERREUX OU METALLIQUE, EN MILIEU ANHYDRE. UTILISATION POUR LA PREPARATION D'EMULSIONS COSMETIQUES ET PHARMACEUTIQUES.THE INVENTION RELATES TO AN EMULSIONING SYSTEM FOR EMULSIONS OF THE WATER-IN-OIL TYPE. THIS EMULSIONING SYSTEM CONSISTS OF AN ALKALINE-EARTH OR METAL LANOLATE AND A STEROL, SITE LANOLATE BEING OBTAINED BY DIRECT ACTION OF LANOLIC ACID AND OF AN ALKALINE-EARTH OR METAL ACETATE, IN ANHYDROUS MEDIUM. USE FOR THE PREPARATION OF COSMETIC AND PHARMACEUTICAL EMULSIONS.
Description
La présente invention concerne un nouveau système émulsionnant seThe present invention relates to a novel emulsifying system
présentant sous forme d'un mélange d'un lanolate alcalino-terreux ou métallique et d'un stérol et l'utilisation de ce système émulsionnant pour la réalisation d'émulsions du type eau-dans-l'huile pour l'industrie cosmétique ou pharmaceutique. Dans le brevet français n 72.10843, il a déjà été proposé presenting in the form of a mixture of an alkaline earth or metal lanolate and a sterol and the use of this emulsifying system for producing water-in-oil type emulsions for the cosmetic industry or pharmaceutical. In French Patent No. 72.10843, it has already been proposed
d'utiliser comme système émulsionnant pour des émulsions du type "eaudans- to use as an emulsifying system for emulsions of the type "eaudans-
l'huile", un mélange constitué d'un lanolate pris dans le groupe constitué par les lanolates de magnésium, de calcium, de lithium, de zinc et d'aluminium et the oil ", a mixture consisting of a lanolate taken from the group consisting of lanolates of magnesium, calcium, lithium, zinc and aluminum and
de lanoline hydrogénée et/ou d'alcool de lanoline. hydrogenated lanolin and / or lanolin alcohol.
Selon ce brevet, les émulsions obtenues sont décrites comme plus économiques car, entre autre, plus riches en eau et présentant une bonne stabilité au stockage à des températures fort éloignées de la température ambiante. Sur le plan cosmétique, ces émulsions ne présentent pas cependant toutes les propriétés souhaitables généralement recherchées pour des crèmes According to this patent, the emulsions obtained are described as more economical because, among others, richer in water and having a good storage stability at temperatures far removed from ambient temperature. From a cosmetic point of view, these emulsions do not, however, exhibit all the desirable properties generally sought for creams.
destinées à une application sur le visage. Ces émulsions du type eau-dans- intended for application on the face. These emulsions of the water-in-water type
l'huile manquent en effet de souplesse et ont une certaine tendance à blanchir oil are lacking flexibility and have a certain tendency to bleach
la peau à l'application.skin to the application.
Par ailleurs, l'utilisation de lanoline hydrogénée et/ou d'alcool de lanoline soulève certaines difficultés du fait non seulement du prix de ces matières premières mais également des fluctuations de leur qualité dues à une peroxydation conduisant à la formation d'odeurs et à des changements de couleur. En vue d'apporter plus de souplesse et de remédier aux inconvénients des émulsions du brevet français 72.10843, divers co-émulsionnants des Furthermore, the use of hydrogenated lanolin and / or lanolin alcohol raises certain difficulties because of not only the price of these raw materials but also the fluctuations in their quality due to peroxidation leading to the formation of odors and color changes. In order to provide more flexibility and to overcome the disadvantages of the emulsions of the French patent 72.10843, various co-emulsifiers of
lanolates ont été testés, notamment des stérols tels que le cholestérol. lanolates were tested, including sterols such as cholesterol.
Si les émulsions obtenues étaient plus souples et plus agréables à l'application, il s'est néanmoins avéré qu'elles étaient de moins bonne Although the emulsions obtained were more flexible and more pleasant to use, they nevertheless proved to be worse.
stabilité que celles du brevet français n 72.10843. stability than those of French Patent No. 72.10843.
Après avoir poursuivi de nombreuses études sur ce système émulsion- After having pursued numerous studies on this emulsion-
nant constitué d'un lanolate et d'un stérol, on a constaté que le problème de la stabilité des émulsions était lié non pas à la nature du co-émulsionnant c'est à dire le stérol, mais au lanolate lui-même selon le procédé de synthèse consisting of a lanolate and a sterol, it was found that the problem of the stability of the emulsions was not related to the nature of the co-emulsifier, ie the sterol, but to the lanolate itself according to the synthesis process
employé.employee.
Dans le brevet français n 72.10843, les lanolates sont préparés par les deux méthodes suivantes: 1 - Soit par double décomposition, méthode qui consiste à réaliser tout d'abord le sel de sodium ou de potassium de l'acide lanolique à une dilution telle qu'il soit en solution isotrope et ensuite à précipiter de In the French patent no. 72.10843, the lanolates are prepared by the following two methods: 1 - either by double decomposition, which method consists firstly of producing the sodium or potassium salt of lanolic acid at a dilution such that it is in isotropic solution and then to precipitate
- 2 - 2568142- 2 - 2568142
cette solution le sel de l'acide lanolique désiré, par addition d'une solution d'un sel minéral par exemple un chlorure, 2 - Soit par action directe d'un hydroxyde alcalin, alcalino-terreux this solution the salt of the desired lanolic acid, by the addition of a solution of a mineral salt for example a chloride, 2 - or by direct action of an alkaline hydroxide, alkaline-earthy
ou métallique sur l'acide lanolique. or metallic on lanolic acid.
Ces deux procédés ont en commun le fait qu'ils sont réalisés en milieu aqueux et qu'il en résulte donc la présence de certains savons basiques These two processes have in common the fact that they are carried out in an aqueous medium and that therefore results in the presence of certain basic soaps
indésirables difficilement éliminables. undesirable problems.
La présence de ces savons basiques étant susceptible de nuire à la stabilité des émulsions lorsque le lanolate est associé à un stérol, d'autres procédés de préparation des lanolates ont été essayés notamment le procédé consistant à faire réagir directement l'acide lanolique avec un acetate alcalino-terreux ou métallique et à éliminer par chauffage sous vide l'acide The presence of these basic soaps being likely to affect the stability of the emulsions when the lanolate is combined with a sterol, other processes for the preparation of lanolates have been tried, in particular the process of reacting the lanolic acid with an acetate directly. alkaline earth or metal and to be removed by heating under vacuum the acid
acétique formé.acetic formed.
On a alors constaté de façon tout à fait surprenante que les lanolates, préparés par ce dernier procédé, associés à un stérol tel que le cholestérol conduisaient à des émulsions eau-dans-l'huile très stables et It was then quite surprising that the lanolates prepared by this latter method, combined with a sterol such as cholesterol, resulted in very stable water-in-oil emulsions.
présentant de bonnes propriétés d'étalement. having good spreading properties.
Par ailleurs, les lanolates obtenus par ce procédé présentent une meilleure solubilité dans la phase grasse des émulsions du fait de l'absence Moreover, the lanolates obtained by this process have a better solubility in the fatty phase of the emulsions because of the absence
totale de savons basiques.total of basic soaps.
La présente invention a donc pour objet, à titre de produit The subject of the present invention is therefore, as a product
industriel nouveau, un système émulsionnant pour émulsions du type "eaudans- new industrial system, an emulsifying system for emulsions of the "water-based" type.
l'huile" constitué d'un lanolate de métal alcalino-terreux ou métallique et d'un stérol, ledit lanolate étant obtenu par action directe de l'acide the oil "consisting of an alkaline earth or metal lanolate and a sterol, said lanolate being obtained by direct action of the acid
lanolique et d'un acétate alcalino-terreux ou métallique, en milieu anhydre. lanolin and an alkaline-earth or metal acetate, in anhydrous medium.
Selon l'invention, les lanolates alcalino-terreux et métallique sont de préférence les lanolates de calcium, de magnésium, de zinc, de cuivre According to the invention, the alkaline earth and metal lanolates are preferably lanolates of calcium, magnesium, zinc, copper
ou d'aluminium.or aluminum.
Les lanolates alcalino-terreux, notamment le lanolate de magnésium, Alkaline earth lanolates, especially magnesium lanolate,
permettent de conduire à l'obtention d'excellentes émulsions du type eaudans- make it possible to obtain excellent emulsions of the water-loving type.
l'huile d'une grande stabilité et d'une application aisée due aux bonnes oil of great stability and easy application due to the good
propriétés d'étalement.spreading properties.
Comme ceci a été mentionné ci-dessus,le procédé d'obtention des As mentioned above, the process for obtaining the
lanolates, destinés à être utilisés en association avec un stérol comme co- lanolates, for use in combination with a sterol as co-
émulsionnant, présente une importance primordiale. emulsifier, is of paramount importance.
Ce procédé, simple dans sa mise en oeuvre, consiste à faire réagir directement, en milieu anhydre, l'acide lanolique et un acétate de métal alcalino-terreux ou métallique et à éliminer, par chauffage sous vide, l'acide This process, simple in its implementation, consists in reacting directly, in anhydrous medium, the lanolic acid and an alkaline earth metal or metal acetate and to be removed, by heating under vacuum, the acid
acétique formé permettant ainsi de déplacer au maximum l'équilibre. shaped acetic, thus making it possible to move the balance as much as possible.
La réaction est généralement conduite sous azote à une température comprise entre 80 et 150 C pendant un temps suffisant pour éliminer au maximum, par distillation sous vide, l'acide acétique formé en cours de réaction. Le rendement de la réaction est généralement compris entre 90 et 99 % par rapport à l'acide lanolique de départ. Si on le souhaite, les lanolates obtenus peuvent être ultérieurement purifiés par addition, au mélange, d'un solvant aromatique tel que du toluène ce qui permet par entrainement azéotropique, à une température comprise entre et 140 C d'éliminer les traces d'acide acétique éventuellement The reaction is generally carried out under nitrogen at a temperature of between 80 and 150 ° C. for a time sufficient to eliminate, to a maximum, by vacuum distillation, the acetic acid formed during the reaction. The yield of the reaction is generally between 90 and 99% relative to the starting lanolic acid. If desired, the lanolates obtained can be further purified by adding, to the mixture, an aromatic solvent such as toluene which allows, by azeotropic entrainment, at a temperature of between 140 ° C. and 140 ° C., to eliminate traces of acid. possibly acetic
subsistantes.remaining.
Selon une variante de ce procédé, la réaction entre l'acide lanolique et l'acétate alcalino-terreux ou métallique, peut être effectuée et terminée en présence d'une huile de point d'ébullition élevé, cosmétiquement According to a variant of this process, the reaction between the lanolic acid and the alkaline-earth or metal acetate may be carried out and terminated in the presence of a high-boiling oil, cosmetically
ou pharmaceutiquement acceptable telle que par exemple l'huile de vaseline. or pharmaceutically acceptable such as for example vaseline oil.
On obtient ainsi, en fin de réaction, les lanolates en solution dans une huile pouvant constituer une partie de la phase grasse d'émulsions du type eau-dans-l'huile. Parmi les stérols utilisables comme co- émulsionnants du nouveau système émulsionnant selon l'invention, on peut tout particulièrement citer le Thus, at the end of the reaction, the lanolates in solution in an oil which can constitute a part of the fatty phase of emulsions of the water-in-oil type are obtained. Among the sterols that can be used as co-emulsifiers of the new emulsifying system according to the invention, mention may be made especially of
cholestérol, et le e -sitostérol.cholesterol, and e-sitosterol.
Dans le système émulsionnant selon l'invention, le rapport poids de lanolate/poids de stérol est compris entre environ 95/5 et 40/60 le rapport In the emulsifying system according to the invention, the weight ratio of lanolate / sterol weight is between about 95/5 and 40/60 the ratio
préférentiel étant d'environ 90/10. preferential being about 90/10.
Selon une variante de l'invention le lanolate alcalino-terreux ou métallique peut être associé à au moins un sel alcalino-terreux ou métallique d'un autre acide gras tel que par exemple un stearate ou un oléate de calcium, de magnésium, de zinc, de cuivre ou d'aluminium, la proportion du sel alcalino- terreux ou métallique de cet autre acide gras n'étant généralement According to one variant of the invention, the alkaline earth or metal lanolate may be associated with at least one alkaline earth or metal salt of another fatty acid such as, for example, a stearate or oleate of calcium, magnesium or zinc. of copper or aluminum, the proportion of the alkaline earth metal salt of this other fatty acid generally not being
pas supérieure à 25% en poids par rapport au poids du lanolate alcalino- not more than 25% by weight relative to the weight of the alkaline lanolate
terreux ou métallique.earthy or metallic.
Selon cette variante le mélange du lanolate alcalino-terreux ou métallique et du sel alcalino-terreux ou métallique d'un autre acide gras est obtenu à l'aide du procédé tel que décrit ci-dessus mais au départ d'un mélange d'acide lanolîque et de l'autre acide gras que l'on souhaite associer According to this variant, the mixture of the alkaline earth or metal lanolate and the alkaline earth metal salt of another fatty acid is obtained using the process as described above but starting from an acid mixture. lanolica and the other fatty acid that we want to associate
dans la proportion choisie.in the chosen proportion.
La présente invention a également pour objet des émulsions souples du type eau-dans-l'huile comportant une phase eau, une phase grasse et un The subject of the present invention is also flexible emulsions of the water-in-oil type comprising a water phase, a fatty phase and a
système émulsionnant tel que défini ci-dessus. emulsifying system as defined above.
Ces émulsions qui peuvent constituer des véhicules cosmétiques ou pharmaceutiques, présentent une viscosité comprise entre 80 et 85 poises cTest These emulsions, which may constitute cosmetic or pharmaceutical vehicles, have a viscosity of between 80 and 85 poises.
4 25681424 2568142
à dire plus faibles que celles des émulsions du brevet français n0 72. 10843 to say weaker than those of the emulsions of French Patent No. 72 10843
qui sont de l'ordre de 100 à 110 poises. which are of the order of 100 to 110 poises.
Dans ces émulsions, la concentration en système émulsionnant selon l'invention est généralement comprise entre 3 et 20 % et de préférence entre 5 et 12 % par rapport au poids total de l'émulsion. Le rapport en poids de la phase grasse à l'émulsionnant est compris In these emulsions, the concentration of emulsifying system according to the invention is generally between 3 and 20% and preferably between 5 and 12% relative to the total weight of the emulsion. The weight ratio of the fatty phase to the emulsifier is included
entre 95/5 et 50/50 mais de préférence ce rapport est d'environ 90/10. between 95/5 and 50/50 but preferably this ratio is about 90/10.
Farmi les produits gras constituant la phase grasse des émulsions, on peut citer: - les huiles hydrocarbonées comme l'huile de paraffine, l'huile de purcellin, le perhydrosqualène et les solutions de cires microcristallines dans les huiles, - les huiles animales ou végétales comme l'huile d'amande douce, l'huile d'avocat, l'huile de calophylum, la lanoline, l'huile de ricin, l'huile de cheval, l'huile de pore, l'huile de sésame, l'huile d'olive, l'huile de jojoba, l'huile de karité, l'huile d'hoplostéthus, les huiles minérales dont le point initial de distillation à pression atmosphérique est d'environ 250 C et le point final de l'ordre de Fatty products constituting the fatty phase of the emulsions include: hydrocarbon-based oils such as paraffin oil, purcellin oil, perhydrosqualene and microcrystalline wax solutions in oils; animal or vegetable oils such as sweet almond oil, avocado oil, calophylum oil, lanolin, castor oil, horse oil, pore oil, sesame oil, lemon olive oil, jojoba oil, shea oil, hoplostethus oil, mineral oils whose initial point of distillation at atmospheric pressure is about 250 C and the end point of the order of
410 C,410 C,
- les esters saturés ou non tels que les myristates d'alkyle comme ceux d'isopropyle, de butyle ou de cétyle,- le stéarate d'hexadécyle, les palmitates d'éthyle ou d'isopropyle, les triglycérides des acides octanoiques saturated or unsaturated esters such as alkyl myristates, such as isopropyl, butyl or cetyl, hexadecyl stearate, ethyl or isopropyl palmitates, octanoic acid triglycerides;
et décanoIques et le ricinoléate de cétyle. and decanoics and cetyl ricinoleate.
La phase grasse peut également contenir des huiles de silicone solubles dans les autres huiles, tels que le diméthylpolysiloxane, le méthyl The fatty phase may also contain silicone oils soluble in other oils, such as dimethylpolysiloxane, methyl
phényl polysiloxane et le copolymère silicone-glycol. phenyl polysiloxane and the silicone-glycol copolymer.
En vue de favoriser la rétention des huiles, on peut également utiliser des cires telles que la cire de carnauba, la cire de candellila, la In order to promote the retention of oils, it is also possible to use waxes such as carnauba wax, candelilla wax,
cire d'abeille, la cire microcristalline et l'ozokérite. beeswax, microcrystalline wax and ozokerite.
Lorsque les émulsions sont destinées à un usage cosmétique, celles- When the emulsions are intended for cosmetic use, those
ci peuvent se présenter sous forme de crèmes solaires hydratantes ou de crèmes hydratantes pour le visage, le corps ou les mains ainsi que sous la forme de fards à joues hydratants ou de fonds de teint. Dans ce cas, la concentration de la phase eau de l'émulsion est généralement comprise entre 20 et 70 % mais de préférence entre 40 et 60 % en poids par rapport au poids total de l'émulsion. Ces compositions peuvent également se présenter sous forme de sticks solaires hydratants ou de sticks hydratants pour le visage, le corps, ainsi que sous forme de sticks pour les lèvres ou le maquillage des yeux. Dans ce cas, la concentration de la phase eau dans l'émulsion est généralement They can be in the form of moisturizing sunscreens or moisturizing creams for the face, body or hands as well as in the form of moisturizing blushes or foundations. In this case, the concentration of the water phase of the emulsion is generally between 20 and 70% but preferably between 40 and 60% by weight relative to the total weight of the emulsion. These compositions can also be in the form of moisturizing solar sticks or moisturizing sticks for the face, the body, as well as in the form of sticks for lips or eye makeup. In this case, the concentration of the water phase in the emulsion is generally
comprise entre 5 et 70 % en poids par rapport au poids total de l'émulsion. between 5 and 70% by weight relative to the total weight of the emulsion.
Les compositions cosmétiques peuvent contenir tous les ingrédients généralement utilisés en cosmétique et en particulier des colorants, des pigments, des filtres solaires, des parfums, des conservateurs tel que le para-hydroxybenzoate de méthyle ou le para-hydroxybenzoate de propyle ainsi que des coémulsionnants comme par exemple le produit vendu par la Société The cosmetic compositions may contain all the ingredients generally used in cosmetics and in particular dyes, pigments, sunscreens, perfumes, preservatives such as methyl para-hydroxybenzoate or propyl para-hydroxybenzoate and coemulsifiers such as for example the product sold by the Company
Goldschmidt sous la dénomination de "PROTEGIN W." Goldschmidt under the name of "PROTEGIN W."
Ces compositions peuvent en outre contenir certains principes actifs non seulement pour l'entretien de la peau mais également pour améliorer ses These compositions may further contain certain active ingredients not only for the maintenance of the skin but also to improve its properties.
propriétés notamment son élasticité. properties including its elasticity.
Parmi ces substances, on peut en particulier citer les humectants tels que la thiamorpholinone et ses dérivés, les vitamines, les agents revitalisants, les dérivés protéiniques tels que l'élastine et le collagène etc... Les émulsions selon l'invention peuvent également constituer un véhicule pour certains principes actifs thérapeutiques, les compositions se Among these substances, mention may in particular be made of humectants such as thiamorpholinone and its derivatives, vitamins, revitalizing agents, protein derivatives such as elastin and collagen, etc. The emulsions according to the invention may also constitute a vehicle for certain therapeutic active ingredients, the compositions are
présentant sous forme de crèmes.presenting in the form of creams.
Parmi les substances actives préférées pour ce type de véhicule, on peut en particulier citer: Among the preferred active substances for this type of vehicle, mention may in particular be made of:
- Les anti-inflammatoires notamment les corticoïdes tels que l'hydro- - Anti-inflammatories, especially corticosteroids such as hydro-
cortisone, le difluprednate, le B -méthasone ou le dexaméthasone, - Les antibiotiques tels que l'érythromycine, la clindamycine ou la néomycine. Les kératolytiques comme l'acide rétinoïque ou le peroxyde de benzoyle, Les antipsoriasiques tels que l'anthraline et ses dérivés et !'étrétinate, - Les vitamines et dérivés comme le palmitate de vitamine A, la biotine ou le d-panthénol, - Les antifongiques tels que les dérivés de l'imidazole ou le tolnaftate, et, - Les hormones sexuelles, naturelles ou de synthèse comme la progestérone cortisone, difluprednate, beta-methasone or dexamethasone, - antibiotics such as erythromycin, clindamycin or neomycin. Keratolytics such as retinoic acid or benzoyl peroxide, antipsoriatic agents such as anthralin and its derivatives and etretinate; vitamins and derivatives such as vitamin A palmitate, biotin or d-panthenol; antifungal agents such as imidazole derivatives or tolnaftate, and, - sex hormones, natural or synthetic, such as progesterone
ou la testostérone.or testosterone.
Le procédé de préparation des émulsions eau-dans-l'huile consiste, dans un premier stade, à dissoudre le lanolate dans la phase grasse à une température d'environ 100 C et sous forte agitation et dans un deuxième stade, à ajouter le stérol à une température d'environ 80 C après quoi l'on refroidit à température d'environ 40 C et l'on introduit-sous forte agitation la phase eau, préalablement portée à la même température, puis l'on refroidit l'émulsion jusqu'à température ambiante tout en agitant. Si on le souhaite, The method for preparing the water-in-oil emulsions consists, in a first stage, in dissolving the lanolate in the fatty phase at a temperature of approximately 100 ° C. and with vigorous stirring, and in a second stage, in adding the sterol. at a temperature of approximately 80 ° C., after which the mixture is cooled to a temperature of approximately 40 ° C. and the water phase, previously heated to the same temperature, is introduced with vigorous stirring and the emulsion is then cooled at room temperature while stirring. If you wish,
l'on peut affiner l'émulsion en la passant dans un broyeur à cylindres. the emulsion can be refined by passing it through a roll mill.
-6 6- 2568142-6 6- 2568142
Ce procédé tel qu'il vient d'être décrit ci-dessus permet d'obtenir plus particulièrement des crèmes. Pour l'obtention des sticks, l'eau est préalablement chauffée à 80 C et ajoutée au mélange non refroidi, puis on coule à cette température l'émulsion obtenue dans des moules appropriés pour la formation de sticks. Dans le but de mieux faire comprendre l'invention, on va maintenant donner, à titre d'illustration, divers exemples de préparation des lanolates alcalino terreux et métallique ainsi que plusieurs exemples d'émulsions du type "eau-dans-l'huile" à usage cosmétique ou This process as just described above makes it possible to obtain creams more particularly. To obtain the sticks, the water is preheated to 80 ° C. and added to the uncooled mixture, and the emulsion obtained is then cast at this temperature into molds suitable for forming sticks. In order to better understand the invention, will now be given, by way of illustration, various examples of alkaline earth and metal lanolate preparation as well as several examples of emulsions of the type "water-in-oil" for cosmetic use or
pharmaceutique.pharmaceutical.
PREPARATION DES LANOLATESPREPARATION OF LANOLATES
Préparation du lanolate de zinc Dans un récipient approprié muni d' un dispositif pour l'élimination sous vide de l'acide acétique par distillation et d'une Preparation of zinc lanolate In a suitable container provided with a device for the vacuum removal of acetic acid by distillation and
arrivée d'azote, on place 221,7 g d'acide lanolique (0,5 mole). With the addition of nitrogen, 221.7 g of lanolic acid (0.5 mol) are placed.
On chauffe le récipient à une température de 80 C jusqu'à fusion de l'acide lanolique puis l'on ajoute, en une seule fois, 53,77 g, d'acétate de The vessel is heated to a temperature of 80 ° C. until the lanolic acid is melted, then 53.77 g of sodium acetate are added in one go.
zinc, 2H20 (0,245 mole).zinc, 2H 2 O (0.245 moles).
On porte alors le mélange à 120-125 C en vue d'éliminer par distil- The mixture is then brought to 120.degree.-12.degree. C. in order to eliminate by distillation
lation, l'eau et l'acide acétique formés. On applique alors progressivement le vide à l'appareillage (1,99 K Pa) et l'on porte progressivement la température water, and acetic acid formed. The vacuum is then progressively applied to the apparatus (1.99 K Pa) and the temperature is gradually raised.
jusqu'à 137 C.up to 137 C.
Après 35 mn on obtient un premier distillat d'acide acétique et After 35 minutes, a first distillate of acetic acid is obtained and
d'eau (37 g) puis un deuxième distillat (1,66 g) après 40 mn à une tempé- water (37 g) then a second distillate (1.66 g) after 40 minutes at a
rature d'environ 130-135 C sous 1,99 K Pa. about 130-135 ° C. under 1.99 K Pa.
On ajoute ensuite 100 g de toluène et l'on procède alors à un entraînement azéotropique des traces d'acide acétique restantes, à la pression 100 g of toluene are then added and the remaining traces of acetic acid are then azeotropically entrained under pressure.
atmosphérique et à une température de 120 à 130 C. atmospheric and at a temperature of 120 to 130 C.
Ce dernier traitement permet d'éliminer l'acide acétique à un taux This last treatment makes it possible to eliminate acetic acid at a rate
de 97,6 % par rapport à la théorie. 97.6% compared to the theory.
Le lanolate de zinc (233,6 g) est obtenu avec un rendement de 98 - % et présente une acidité totale de 2,075 meq/g Zinc lanolate (233.6 g) is obtained with a yield of 98% and has a total acidity of 2.075 meq / g
(théorie: 2,11 meq/g).(theory: 2.11 meq / g).
Préparation du lanolate de cuivre Dans un récipient approprié muni d'un dispositif pour l'élimination sous vide de l'acide acétique par distillation et d'une arrivée d'azote, on introduit 221,7 g d'acide lanolique (0,5 mole) que l'on porte à 90 C sous Preparation of Copper Lanolate In a suitable container provided with a device for the vacuum removal of acetic acid by distillation and a nitrogen inlet, 221.7 g of lanolic acid (0.5 mole) to 90 C under
azote jusqu'à fusion totale.nitrogen until complete melting.
On ajoute ensuite 50 g (0,245 mole) d'acétate de cuivre monohydraté et l'on porte le mélange sous agitation à une température comprise entre 117 -7 - 50 g (0.245 mole) of copper acetate monohydrate are then added and the mixture is stirred at a temperature of between 117.degree.
2568 1 422568 1 42
et 125 C. Après ralentissement de la distillation, on met l'appareillage sous vide et l'on augmente progressivement la température jusqu'à 135 C sous and 125 ° C. After slowing down the distillation, the equipment is evacuated and the temperature is gradually increased to 135 ° C.
1,99 K Pa.1.99 K Pa.
On obtient ainsi un premier distillat (33,7 g) d'acide acétique et d'eau puis un second distillat (1,15 g) après une heure sous 1,99 K Pa à C. Une purification ultérieure ne s'est pas avérée nécessaire, le lanolate de cuivre obtenu ne présentant plus de traces d'acide acétique résiduel. On obtient ainsi 252 g de lanolate de cuivre avec un rendement de This gives a first distillate (33.7 g) of acetic acid and water and then a second distillate (1.15 g) after one hour under 1.99 K Pa at C. A subsequent purification was not proved necessary, the copper lanolate obtained no longer showing traces of residual acetic acid. 252 g of copper lanolate are thus obtained with a yield of
100 %.100%.
Préparation du lanolate de magnésium Dans un tricol de 6 litres muni d'un dispositif de distillation sous vide et d'une arrivée d'azote, on introduit 2444,2 g d'acide lanolique (5,5 moles) que l'on porte à environ 90 C sous azote. Après fusion de l'acide lanolique, on ajoute alors en une seule fois 578,2 g d'acétate de magnésium 4 H20 (2,7 moles) et l'on continue le chauffage jusqu'à environ 108 C. A cette température, l'acide acétique et l'eau d'hydratation de l'acétate de magnésium commencent à distiller. On porte alors la température du mélange réactionnel Preparation of magnesium lanolate 2444.2 g of lanolic acid (5.5 moles) are introduced into a 6-liter three-necked flask equipped with a vacuum distillation device and a nitrogen inlet. at about 90 ° C under nitrogen. After melting of the lanolic acid, 578.2 g of magnesium acetate 4 H 2 O (2.7 moles) are then added all at once, and the heating is continued to approximately 108 ° C. At this temperature, acetic acid and water of hydration of magnesium acetate begin to distill. The temperature of the reaction mixture is then brought
progressivement à 130 C tout en distillant l'acide acétique formé. gradually at 130 C while distilling the acetic acid formed.
On maintient la température à 130 C pendant environ 2 heures puis lorsque la distillation s'atténue, on met l'appareillage sous vide en vue de The temperature is maintained at 130 ° C. for about 2 hours and then, when the distillation is reduced, the apparatus is placed under vacuum in order to
favoriser l'élimination de l'acide acétique restant. promote the elimination of the remaining acetic acid.
Après 1 heure à 130-135 C sous 1,99 K Pa, on obtient un premier distillat (461 g). On ajoute alors 2505 g d'huile de vaseline et poursuit le chauffage à 130-135 C sous vide (6,65 Pa) pendant 1 heure et l'on obtient un After 1 hour at 130-135 ° C. under 1.99 K Pa, a first distillate (461 g) is obtained. 2505 g of vaseline oil are then added and the heating is continued at 130 ° -135 ° C. under vacuum (6.65 Pa) for 1 hour and a
deuxième distillat (47 g).second distillate (47 g).
Le lanolate de magnésium en solution à 50% dans l'huile de vaseline Magnesium lanolate in 50% solution in petrolatum oil
peut être utilisé tel quel pour la réalisation d'émulsions du type eaudans- can be used as is for the production of emulsions of the type eaudans-
l'huile.oil.
COMPOSITIONS COSMETIQUESCOSMETIC COMPOSITIONS
EXEMPLE 1: Stick pour les lèvres Lanolate de calcium à 50 % dans l'huile de vaseline........ 17,00 g Cholestérol................................... EXAMPLE 1: Stick for the lips Calcium lanolate 50% in petrolatum oil ........ 17.00 g Cholesterol .................. .................
........... 3,00 g Cire d'abeille.........................................DTD: .... 8,00 g Huile de ricin..........................................10, 00 g Huile de vaseline.......................................... 12,00 g Colorants D et C orange n 17.............................. 0,50 g Colorants D et C red 8..................................... 0,50 g Oxyde de titane............................................ 2,30 g Eau + parahydroxybenzoate de méthyle 0,2 %.............QSP 100,00 g -8- EXEMPLE 2: Stick hydratant pour le corps Lanolate de magnésium à 50 % dans l'huile de vaseline...... 8,10 g Cholestérol........................................DTD: ........ 0,90 g Huile de purcellin........................................DTD: . 3,00 g Hulle de vaseline.......................................... 12, 00 g Ozokérite................................................. 8,00 g Eau + para-hydroxybenzoate de méthyle 0,2 %.............QSP 100,00 g EXEMPLE 3: Stick hydratant pour le visage Lanolate de magnésium à 50 % dans l'huile de vaseline...... 12,00 g Cholestérol..........................DTD: ....................... 8,00 g Perhydrosqualène...........................DTD: ............... 5,00 g Ozokérite..........................................DTD: ........ 15,00 g Eau + para-hydroxybenzoate de méthyle à 0,2 %.......... .QSP 100,00 g EXEMPLE 4 - Crème de traitement hydratante Lanolate de cuivre......................................... 3,32 g Cholestérol..........DTD: ...................................... 0,35 g Huile de vaseline...........DTD: ............................... 23,33 g Huile de tournesol................DTD: ........................ 10,00 g Lanoline.................................DTD: ................ 5,00 g Eau + para-hydroxybenzoate de méthyle 0,2 %.......DTD: ......QSP 100,00 g EXEMPLE 5 - Fond de teint hydratant Lanolate de zinc...DTD: ........................................ 6,37 g Cholestérol...............DTD: ................................. 2,25 g Vaseline.........................DTD: .. 10,00 g Huile de vaseline.......................................... 26,38 g Oxyde de fer + oxyde de titane............................. 7,00 g Eau + para-hydroxybenzoate de méthyle à 0,2 %...........QSP 100,00 g EXEMPLE 6 Crème solaire hydratante Lanolate de calcium à 50 % dans l'huile de vaseline........ 6,65 g Cholestérol..............................DTD: ..... 0,35 g Huile de vaseline.......................................... 20,00 g Huile de silicone.......................................... 10, 00 g Filtre solaire "PARSOL 1789" (butyl méthoxy dibenzoyl méthane) vendu par la Société GIVAUDAN..................... 3,00 g Eau + parahydroxybenzoate de méthyle à 0,2 %...........QSP 100,00 g EXEMPLE 7 Crème hydratante teintée Lanolate de magnésium à 50 % dans l'huile de vaseline...... 6,00 g B-Sitostérol..........................................DTD: .... 4,00 g Huile de paraffine......................................... 29,00 g Huile de silicone..........................................3,00 g..DTD: 9 2 682568 1 42........... 3.00 g Beeswax ............................... .......... DTD: .... 8.00 g Castor oil ........................... ............... 10, 00 g Vaseline oil ............................ .............. 12.00 g D and C dyes orange n 17 ......................... ..... 0.50 g Colorants D and C red 8 ................................... .. 0.50 g Titanium oxide ......................................... 2.30 g Water + methyl parahydroxybenzoate 0.2% ............. QSP 100.00 g -8- EXAMPLE 2: Moisturizing body stick Lanolate magnesium 50 % in Vaseline oil ...... 8.10 g Cholesterol ................................ ........ DTD: ........ 0.90 g Purcellin Oil ......................... ............... DTD:. 3.00 g Vaseline Hulle .......................................... 12 , 00 g Ozokerite .............................................. ... 8.00 g Water + methyl para-hydroxybenzoate 0.2% ............. QSP 100.00 g EXAMPLE 3: Moisturizing face stick 50% magnesium lanolate in Vaseline oil ...... 12.00 g Cholesterol .......................... DTD: ..... .................. 8.00 g Perhydrosqualene ........................... DTD: ............... 5.00 g Ozokerite ............................ .............. DTD: ........ 15.00 g Water + 0.2% methyl para-hydroxybenzoate .......... .QSP 100.00 g EXAMPLE 4 - Moisturizing Copper Lanolate Treatment Cream .................................. ....... 3.32 g Cholesterol .......... DTD: .......................... ............ 0.35 g Vaseline oil ........... DTD: .................. ............. 23.33 g Sunflower oil ................ DTD: ............ ............ 10.00 g Lanolin ................................. DTD: ........ ........ 5.00 g Water + methyl para-hydroxybenzoate 0.2% ....... DTD: ...... QSP 100.00 g EXAMPLE 5 - Moisturizing foundation Zinc lanolate ... DTD: ........................................ 6, 37 g Cholesterol ............... DTD: .............................. ... 2.25 g Vaseline ......................... DTD: .. 10.00 g Vaseline oil ...... .................................... 26.38 g Iron Oxide + Titanium Oxide ... .......................... 7.00 g Water + 0.2% methyl para-hydroxybenzoate ........ ... QSP 100.00 g EXAMPLE 6 Moisturizing sun cream Calcium lanolate 50% in petrolatum oil ........ 6.65 g Cholesterol ............ .................. DTD: ..... 0.35 g Vaseline oil .................. ........................ 20.00 g Silicone oil ................... ....................... 10, 00 g Solar filter "PARSOL 1789" (butyl methoxy dibenzoyl methane) sold by the company GIVAUDAN ...... 3.00 g Water + 0.2% methyl parahydroxybenzoate. .......... QSP 100.00 g EXAMPLE 7 Tinted moisturizing cream 50% magnesium lanolate in petrolatum oil ...... 6.00 g B-Sitosterol ..... ..................................... DTD: .... 4.00 g Paraffin oil ......................................... 29.00 g Silicone oil .. ........................................ 3.00 g..DTD: 9 2 682568 1 42
Huile de purcellin......................................... 5,00 g Oxyde de fer + oxyde de titane............................. 3,00 g Eau + parahydroxybenzoate de méthyle à 0,2 %...........QSP 100,00 g EXEMPLE 8 Crème hydratante après soleil Lanolate de magnésium à 50 % dans l'huile de vaseline...... 17,00 g Cholestérol..................................... Purcellin oil ......................................... 5,00 g Oxide of iron + titanium oxide ............................. 3.00 g Water + 0.2% methyl parahydroxybenzoate .. ......... QSP 100.00 g EXAMPLE 8 Moisturizing cream after sun 50% magnesium lanolate in Vaseline oil ...... 17.00 g Cholesterol ....... ..............................
.......... 3,00 g Myristate d'isopropyle..................................DTD: ... 10,00 g Huile de vaseline.......................................... 38,00 g Cire d'abeille............................................. 5,00 g Lanoline................................................... 5,00 g Dpanthénol................................................ 2,00 g Eau + para-hydroxybenzoate de méthyle à 0,2 %...........QSP 100,00 g EXEMPLE 9 Crème hydratante pour le visage Lanolate de magnésium à 50 % dans l'huile de vaseline...... 5,70 g Cholestérol................................DTD: ................ 0,15 g Huile de paraffine................................DTD: ......... 23,15 g Palmitate d'isopropyle..................................DTD: ... 4,00 g Huile de purcellin......................................... 3,00 g Huile de sésame............................................ 4,00 g Eau + para-hydroxybenzoate de méthyle à 0,2 %...........QSP 100,00 g EXEMPLE 10: Crème de soins hydratante Lanolate de magnésium à 50 % dans l'huile de vaseline..... 2,85 g Cholestérol.................................DTD: ............... 0,15 g Huile de vaseline..................................DTD: ........ 4,00 g Protegin W vendu par la Société GOLDSCHMIDT...............DTD: 30,00 g Eau + para-hydroxybenzoate de méthyle 0,2 %.............QSP 100, 00 g..DTD:.......... 3.00 g Isopropyl myristate ................................ ..DTD: ... 10.00 g Vaseline oil .................................... ...... 38.00 g Beeswax .................................... ......... 5.00 g Lanolin .................................... ............... 5.00 g Dpanthenol .............................. .................. 2.00 g Water + 0.2% methyl para-hydroxybenzoate ............ QSP 100.00 g EXAMPLE 9 Moisturizing facial cream 50% magnesium lanolate in petrolatum oil ...... 5.70 g Cholesterol .................... ............ DTD: ................ 0.15 g Paraffin oil ............. ................... DTD: ......... 23.15 g Isopropyl palmitate ............ ...................... DTD: ... 4.00 g Purcellin oil ................ ......................... 3.00 g Sesame oil .................. .......................... 4.00 g Water + 0.2% methyl para-hydroxybenzoate ........ ... QSP 100.00 g EXAMPLE 10: Hydra care cream aunt 50% magnesium lanolate in Vaseline oil ..... 2.85 g Cholesterol ........................... ...... DTD: ............... 0.15 g Vaseline oil .................... .............. DTD: ........ 4.00 g Protegin W sold by the company GOLDSCHMIDT ............... DTD: 30.00 g Water + methyl para-hydroxybenzoate 0.2% ............. QSP 100.00 g..DTD:
Claims (11)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8411862A FR2568142B1 (en) | 1984-07-26 | 1984-07-26 | |
BE0/215398A BE902969A (en) | 1984-07-26 | 1985-07-25 | NOVEL EMULSIFYING SYSTEM BASED ON AN ALKALINE EARTH OR METAL LANOLATE AND WATER-IN-OIL-TYPE EMULSIONS BASED ON THIS EMULSIFYING SYSTEM |
NL8502130A NL8502130A (en) | 1984-07-26 | 1985-07-25 | EMULSIVE SYSTEM FOR WATER-IN-OIL TYPE EMULSIONS AND EMULSIONS CONTAINING SUCH A SYSTEM. |
ES546104A ES8700081A1 (en) | 1984-07-26 | 1985-07-25 | Emulsifier based on an alkaline earth metal lanolate or other metal lanolate and water-in-oil emulsions based on this emulsifying system |
AU45345/85A AU4534585A (en) | 1984-07-26 | 1985-07-25 | Lanolate and sterol emulsifying system for water-in-oil emulsions |
CH3244/85A CH664296A5 (en) | 1984-07-26 | 1985-07-25 | PROCESS FOR THE PREPARATION OF A WATER-IN-OIL-TYPE EMULSION. |
IT21708/85A IT1187708B (en) | 1984-07-26 | 1985-07-25 | EMULSIFYING SYSTEM BASED ON AN ALKALINE-TERROSOUS LANOLATE OR METALLIC AND WATER-TYPE EMULSIONS IN CLIO BASED ON THIS SYSTEM EMULSIONATE |
CA000487499A CA1254512A (en) | 1984-07-26 | 1985-07-25 | Metal or earth alkali lanolate emulsifying system and water-in-oil type emulsions containing this system |
DE19853526669 DE3526669A1 (en) | 1984-07-26 | 1985-07-25 | NEW EMULSION SYSTEM BASED ON AN ALKALINE OR METAL LANOLATE AND EMULSIONS OF THE WATER-IN-OEL TYPE BASED ON THIS EMULSION SYSTEM |
JP60165643A JPS6150632A (en) | 1984-07-26 | 1985-07-25 | Novel emulsified system |
GB08518776A GB2162439B (en) | 1984-07-26 | 1985-07-25 | Emulsifier based on an alkaline earth metal lanolate or other metal lanolate and water-in-oil emulsions based on this emulsifying system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8411862A FR2568142B1 (en) | 1984-07-26 | 1984-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2568142A1 true FR2568142A1 (en) | 1986-01-31 |
FR2568142B1 FR2568142B1 (en) | 1989-11-17 |
Family
ID=9306523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8411862A Expired FR2568142B1 (en) | 1984-07-26 | 1984-07-26 |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS6150632A (en) |
AU (1) | AU4534585A (en) |
BE (1) | BE902969A (en) |
CA (1) | CA1254512A (en) |
CH (1) | CH664296A5 (en) |
DE (1) | DE3526669A1 (en) |
ES (1) | ES8700081A1 (en) |
FR (1) | FR2568142B1 (en) |
GB (1) | GB2162439B (en) |
IT (1) | IT1187708B (en) |
NL (1) | NL8502130A (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3836971C1 (en) * | 1988-10-31 | 1990-05-17 | Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De | |
DE19643237A1 (en) * | 1996-10-19 | 1998-04-23 | Beiersdorf Ag | Cosmetic and dermatological pens with high water content |
ES2647357T3 (en) | 2001-09-29 | 2017-12-21 | Beiersdorf Ag | Cosmetic and dermatological bars |
DE10340417C5 (en) * | 2003-09-02 | 2011-05-05 | Sebapharma Gmbh & Co. Kg | Cosmetic or dermatological preparation with phytosterols in the form of a W / O emulsion |
ES2366614T3 (en) * | 2004-12-06 | 2011-10-21 | SEBAPHARMA GMBH & CO. KG | COSMETIC OR DERMATOLOGICAL COMPOSITION IN THE FORM OF WATER-OIL EMULSION CONTAINING PHYTOSTEROLS. |
JP2013193960A (en) * | 2012-03-16 | 2013-09-30 | Goshu Yakuhin Kk | Hand cream |
JP5944707B2 (en) * | 2012-03-21 | 2016-07-05 | 御木本製薬株式会社 | Water-in-oil or oil-in-water oil-in-water emulsions |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1271037A (en) * | 1958-07-17 | 1961-09-08 | Ghent Sa | Process for the preparation of polyvalent metal soaps |
FR2132130A1 (en) * | 1971-03-29 | 1972-11-17 | Oreal | |
FR2197959A1 (en) * | 1971-04-23 | 1974-03-29 | Percy Jullan | |
EP0015030A2 (en) * | 1979-02-23 | 1980-09-03 | THE PROCTER & GAMBLE COMPANY | Skin conditioning compositions |
EP0077742A1 (en) * | 1981-10-20 | 1983-04-27 | L'oreal | Copper lanolate and topic compositions containing it |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB172012A (en) * | 1920-11-23 | 1923-02-22 | Jacques Duclaux | Process for treating washing waters and particularly washing waters for wools |
GB400797A (en) * | 1933-01-05 | 1933-11-02 | Ig Farbenindustrie Ag | Manufacture of wool grease compositions suitable for use as driers for paints, varnishes and lacquers |
GB439269A (en) * | 1934-02-14 | 1935-12-03 | Henryk Cohn | An improved process for obtaining a highly swellable body from waxes |
NL76491C (en) * | 1951-02-17 | |||
US3983147A (en) * | 1973-06-12 | 1976-09-28 | Dai-Ichi Kogyo Seiyaku Co., Ltd. | Separation of wool fatty acid |
FR2462192B1 (en) * | 1979-08-02 | 1986-08-01 | Oreal | "WATER-IN-OIL" TYPE EMULSIONS FOR USE AS COSMETIC SUPPORTS OR PHARMACEUTICAL EXCIPIENTS |
-
1984
- 1984-07-26 FR FR8411862A patent/FR2568142B1/fr not_active Expired
-
1985
- 1985-07-25 CH CH3244/85A patent/CH664296A5/en not_active IP Right Cessation
- 1985-07-25 DE DE19853526669 patent/DE3526669A1/en active Granted
- 1985-07-25 CA CA000487499A patent/CA1254512A/en not_active Expired
- 1985-07-25 ES ES546104A patent/ES8700081A1/en not_active Expired
- 1985-07-25 AU AU45345/85A patent/AU4534585A/en not_active Abandoned
- 1985-07-25 GB GB08518776A patent/GB2162439B/en not_active Expired
- 1985-07-25 IT IT21708/85A patent/IT1187708B/en active
- 1985-07-25 BE BE0/215398A patent/BE902969A/en not_active IP Right Cessation
- 1985-07-25 NL NL8502130A patent/NL8502130A/en not_active Application Discontinuation
- 1985-07-25 JP JP60165643A patent/JPS6150632A/en active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1271037A (en) * | 1958-07-17 | 1961-09-08 | Ghent Sa | Process for the preparation of polyvalent metal soaps |
FR2132130A1 (en) * | 1971-03-29 | 1972-11-17 | Oreal | |
FR2197959A1 (en) * | 1971-04-23 | 1974-03-29 | Percy Jullan | |
EP0015030A2 (en) * | 1979-02-23 | 1980-09-03 | THE PROCTER & GAMBLE COMPANY | Skin conditioning compositions |
EP0077742A1 (en) * | 1981-10-20 | 1983-04-27 | L'oreal | Copper lanolate and topic compositions containing it |
Also Published As
Publication number | Publication date |
---|---|
CA1254512A (en) | 1989-05-23 |
DE3526669C2 (en) | 1993-07-08 |
JPH0527449B2 (en) | 1993-04-21 |
BE902969A (en) | 1986-01-27 |
NL8502130A (en) | 1986-02-17 |
AU4534585A (en) | 1986-01-30 |
CH664296A5 (en) | 1988-02-29 |
GB2162439A (en) | 1986-02-05 |
IT1187708B (en) | 1987-12-23 |
JPS6150632A (en) | 1986-03-12 |
GB2162439B (en) | 1987-10-28 |
GB8518776D0 (en) | 1985-08-29 |
IT8521708A0 (en) | 1985-07-25 |
FR2568142B1 (en) | 1989-11-17 |
ES8700081A1 (en) | 1986-10-16 |
ES546104A0 (en) | 1986-10-16 |
DE3526669A1 (en) | 1986-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0145607B1 (en) | Aqueous or anhydrous cosmetic composition containing a fatty phase based on karite oil | |
EP1092422B1 (en) | Composition, particularly for cosmetics containing a sapogenin | |
CA1110970A (en) | Oil-in-water or water-in-oil type emulsions, and cosmetics derived from said emulsions | |
CH671395A5 (en) | ||
FR2604357A1 (en) | PHARMACEUTICAL AND COSMETIC COMPOSITION ANTI-ACNE | |
FR2571048A1 (en) | NOVEL RETINOIC ACID NAPHTHALENIC DERIVATIVES, PROCESSES FOR PREPARING THEM AND MEDICAMENTOUS AND COSMETIC COMPOSITIONS CONTAINING SAME | |
FR2604435A1 (en) | UNSATURATED AROMATIC PEROXIDES AND THEIR USE IN THERAPEUTICS AND COSMETICS | |
CA2569685A1 (en) | Indolecarboxylic compounds and their use as pharmaceutical compounds | |
BE1000427A4 (en) | Benzofuran DERIVATIVES, METHODS OF PREPARATION AND DRUG COMPOSITIONS AND COSMETICS CONTAINING. | |
FR2514643A1 (en) | COPPER LANOLATE AND ANTI-ACNE COSMETIC COMPOSITIONS CONTAINING THE SAME | |
EP0974586A1 (en) | 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same | |
FR2568142A1 (en) | ||
CA2446149C (en) | Vitamin d analogues | |
FR2462192A1 (en) | "WATER-IN-OIL" EMULSIONS FOR USE AS COSMETIC MEDIA OR PHARMACEUTICAL EXCIPIENTS | |
CA2210365C (en) | New derivative of kojic acid and its use as a depigmenting agent | |
EP0297995B1 (en) | Polycyclic aromatic compounds, process for their preparation and their use in human and animal medicine and in cosmetics | |
EP1371658A1 (en) | Derivative of glucose and vitamin F, compositions containing it, its uses and its preparation | |
CA2013557A1 (en) | Cosmetic and pharmaceutical compositions containing lipophilic benzylidene camphor derivatives and new lipophilic benzylidene camphor derivatives | |
FR2596759A1 (en) | NOVEL CHROMANE AND THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND DRUG AND COSMETIC COMPOSITIONS CONTAINING SAME | |
CA1325811C (en) | Norbornane derivatives, process for their preparation, and cosmetic and pharmaceutical compositions containing them | |
EP0404640A1 (en) | 5,6,7,8-Tetrahydro-1-naphtalenol derivatives, process for their preparation and their use as antioxidants in cosmetic and pharmaceutical compositions | |
CH667452A5 (en) | 1-SUBSTITUTED DERIVATIVES OF METHOXY-4 TRIMETHYL-2,3,6 BENZENE, PROCESS FOR THEIR PREPARATION AND MEDICINAL AND COSMETIC COMPOSITIONS CONTAINING THEM. | |
FR2496642A1 (en) | ||
FR2532175A1 (en) | COSMETIC PRODUCT | |
EP0925781A1 (en) | Skin whitening composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |